On the weekend the FDA rejected $SMMT drug. PFS win, but OS missed: HR 0.79, p=0.057. Not enough.
48 hours later Sellas $SLS hits OS outright in AML:
24.0 vs 14.7 months median survival
HR 0.59, p=0.035
The catch: 126 patients, 80 deaths. A small trial, but on the right endpoint.
The FDA just told everyone which endpoint it pays for. Sellas plans its BLA for 1H 2027
1
323
This must be the reason copper is rolling over. Clearly bringing on too much supply!
Britain's copper crime wave has become brazen and out of control, with thieves filming themselves slicing out cables all over the country to cash in on the precious metal inside.
@TomSkyNews investigates.
📺 trib.al/hO3OZDT
1
1
314
Merlin_Asset retweeted
Confirmed: he blew up, loaded up on calls hoping to make it all back quick, then blew up again.
Quebecor’s $QBR.B.TO offer is worth about C$19.45 per share, valuing Telus $T.TO at around C$31 billion ($21.7 billion). That would be a 60% premium to Friday’s closing share price.
209
CANACCORD $CF.TO ENTERS INTO AGREEMENT TO BE TAKEN PRIVATE BY CHAIRMAN AND CEO DAN DAVIAU
Shareholders to receive aggregate consideration of $15.27 per common share comprised of $7.45, plus proceeds of £4.15
Merlin_Asset retweeted
NP View: Carney’s expanded immigration plan is crashing our quality of life
nationalpost.com/opinion/np-…
Merlin_Asset retweeted
Ok let me get this straight:
- The most charismatic CEO in AI, who happens to be an open source proponent (which is obviously bad for Frontier models), gets ousted because of “surprise” leaks about his affair(s)
- Microsoft suffers a global outage, just a few days after Anthropic unveils an Office competitor
- just as Anthropic is about to IPO
… and none of you think this is weird at all?!!
The Golden Age of Rift ™️ is upon us
Altius Minerals to Acquire TNR Gold in C$122 Million Cash
The deal represents an implied consideration of about C$0.48 per TNR share, a 60% premium to the stock's closing price on Tuesday, which is listed on the TSX Venture Exchange
Congrats @YellowLabLife on surfacing the value.
Mirum $MIRM brelovitug in hepatitis delta. Second Phase 3 win in two months.
AZURE-4 at week 24:
300 mg weekly: 59% hit the combined endpoint
900 mg monthly: 44%
Delayed-treatment arm: 0%
The real story is the 108-week data in cirrhosis patients, with 100% virologic response and 100% ALT normalization (only 15 patients).
Half of these patients are cirrhotic and there's no approved HDV drug in the US. BLA is planned for H1 2027, and Vir is chasing the same market.
90
Merlin_Asset retweeted
For the first time in decades, America is about to start refining raw tin at scale. A first-of-its-kind plant in Henry County, Virginia, is set to begin production in 2027. A new deal secures its supply: up to 3,600 metric tons a year from the Democratic Republic of the Congo. Tin holds together the circuit boards in your phone, your car, and our defense systems. American workers will now smelt Congolese tin in the United States, creating jobs on both sides of the Atlantic. That is Pax Silica and the U.S.-DRC Strategic Partnership Agreement at work.
mining.com/alphamin-directs-…
Anthropic $ANT Retracts IPO Filing Details, Citing Inaccuracy: Rtrs
reuters.com/business/anthrop…
83
Faeth Thera $FTH printed "positive" Phase 2 data this morning. Stock went from +18% to -22% premarket.
Headline: 33% confirmed response (12/36). 44% in PIK3CA-mutant (7/16).
Fine print: single-arm, no control. And 64% grade 3+ treatment-related side effects, under a release that says "generally well tolerated."
Next up: they want a Phase 3. The market already voted on the toxicity given it finished down 42%.
164
Zura Bio $ZURA down ~68% premarket after tibulizumab missed its Phase 2 in hidradenitis suppurativa.
AN count reduction at week 16:
300 mg: 56.0%
150 mg: 58.1%
Placebo: 52.5%
That's the story. The drug didn't fail to move patients. Placebo moved them almost as much.
HS keeps punishing trials with huge placebo responses. If you can't separate signal from noise in who responds, you need a bigger trial or a smarter one.
2
425
Merlin_Asset retweeted
Important Fact About Sam Cooper: The Liberal Government & All Liberal Operatives HATE SAM
For the last 15 Years the Liberal Establishment has insisted everything Sam publishes is untrue or distorted
But in the end, this is what we learn about Sam' work:
EVERY WORD IS TRUE
Key post from @scoopercooper (Aug 24, 2026):
“I’d be worried if I was a Canadian bank or developer etc with exposure to Iranian currency exchanges and Chinese underground banking, that is major exposure risk given Bessent’s announcement. Speaking of economic warfare. People don’t know the half of the tools available to DC.” @scoopercooper
This was posted the same day Treasury Secretary Scott Bessent launched Operation Economic Outcast, an aggressive campaign to sever Iran’s financial lifelines (including digital assets, secondary sanctions on facilitators, and targeting networks enabling IRGC funding). home.treasury.gov
This is mind blowing to me……TIA though.
This is Africa. #gold
AFRICA ‘PREMIUM GOLD’ seller shows off his operation on INSTAGRAM
Workers form HUMAN CONVEYOR BELT, passing material DOZENS OF METERS through mine
94
Servier’s $1.55B bet for Edgewise's sevasemten just backfired.
This week the 175-patient, 18-month Becker muscular dystrophy pivotal missed its primary endpoint and every secondary.
A biomarker win isn't a functional win. $EWTX
The warning was in the Phase 2. It won on a biomarker (creatine kinase) but never hit significance on the same functional scale the pivotal used.
222
























